Immunocore Holdings plc (IMCR)

Every figure this model derived for IMCR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 6,195,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 880,211,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,051,044,000 AssetsCurrent 2026-06-30
current liabilities 235,198,000 LiabilitiesCurrent 2026-06-30
equity 419,798,000 StockholdersEquity 2026-06-30
interest expense 12,209,000 InterestExpenseDebt 2026-06-30
ocf -10,712,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 430,775,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 33,882,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IMCR on one particular measure came for.

RatioValue
cash operating margin3.46
current ratio4.48
current ratio reported4.47
deferred revenue growth-3.54
dilution pct0.71
fcf margin-3.92
growth cv1.68
interest cover-1.85
operating margin-5.24
owner earnings margin-11.79
revenue growth20.95
revenue growth per share20.1
rule of 4015.71
sbc pct revenue7.87

What to be careful about

What this model itself distrusts about IMCR's figures. Written by the derivation as it ran, not added afterwards.